Two panels of experts have been assembled to review the applications submitted to these competitions.

Panel B: Cell and molecular, medical physics and biomedical studies
Anne Marie Mes-Masson,
Chair


Anthony Joshua


Thomas Kislinger


Gerardo Ferbeyre


Amina Zoubeidi


Jacques Lapointe


Christopher Ong


Olivier Barbier


David Berman


Bharati Bapat


Xuesen Dong,
Scientific Officer

Brian Rossnagel,
Community Representative
Centre de recherche du Centre hospitalier de l’Université de Montréal
Montreal, QC

Princess Margaret Cancer Centre
Toronto, ON

Princess Margaret Cancer Centre
Toronto, ON

Université de Montréal
Montreal, QC

Vancouver Prostate Centre
Vancouver, BC

McGill University
Montreal, QC

Vancouver Prostate Centre
Vancouver, BC

Université Laval
Quebec, QC

Queen's University
Kingston, ON

Lunenfeld-Tannenbaum Research Institute
Toronto, ON
     
Vancouver Prostate Centre
Vancouver, BC
  
Saskatoon, SK

Panel A-C: Applied and Clinical: Survivorship, behavioural and psychosocial studies and clinical and translational studies
Kim Chi,
Chair

Andrew Loblaw


Gregory Czarnota


Jehonathan Pinthus


Cheri Van Patten


Fred Saad


Murray Krahn


John Thoms,
Scientific Officer

Winston Isaac,
Community Representative
BC Cancer Agency
Vancouver, BC

Sunnybrook Health Sciences Centre
Toronto, ON

Sunnybrook Health Sciences Centre
Toronto, ON

McMaster University
Hamilton, ON
   
BC Cancer Agency
Vancouver, BC

Université de Montreal
Montreal, QC

University Health Network
Toronto, ON

Memorial University of Newfoundland
St. John’s, NF

Toronto, ON
    
 

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive